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Abstract:
15q11-q13 interstitial triplication is a rare condition resulting in a tetrasomy of imprinted
genes in the Prader-Willi/Angelman critical region (PWACR), with only 12 cases reported to
date. The genotype-phenotype correlation is advancing, with a range of varying features such
as craniofacial dysmorphism, developmental delay (DD), hypotonia, ataxia, seizures,
behavioral impairment, and autism spectrum disorder. We present an eight-year-old female
patient who displays mild craniofacial dysmorphism (strabismus, arched eyebrows, midface
hypoplasia, long philtrum, thin upper lip), global developmental delay, and all the previously
reported neurological features in relation to tetrasomy of this region. Whole genome single
nucleotide polymorphism (SNP) microarray analysis detected a 6.05 Mb triplication at
15q11.2-q13.1 and a 3.48 Mb duplication at 15q13.1-q13. Our patient is the first case to
encompass the full spectrum of reported features related to tetrasomy of this region. In
addition, she has a complex chromosomal rearrangement (CCR) spanning the largest region
of chromosome 15q11-q13 thus far. Our study contributes to the genotype-phenotype
correlation regarding developmental delay especially impacting speech, and expands the
prognosis for achievement of developmental milestones with early utilization of intensive
speech, physical, and occupational therapies. Finally, we acknowledge the barriers our
patient and her family faced to access specialized genetic clinical care and advocate for
expanded access to clinical genetic care for under-represented populations.
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Introduction:

Chromosome rearrangement syndromes present an extensive range of clinically distinct
symptoms; therefore, establishing a phenotypic correlation for the spectrum of these
presentations is critical to providing children with medical complexity (CMC) early diagnosis
and treatment. This is especially crucial when serving a patient population with socioeconomic
barriers to access for genomic testing.
The chromosome 15 is particularly susceptible to structural variations (SV), such as
deletions, duplications, triplications, and translocations. These abnormalities occur in recognized
breakpoints (BP) numbered 1 to 5 encompassing 15q11-q14 region (Ungaro et al., 2001; Roberts
et al., 2003). The identification and categorization of the SV breakpoints on chromosome 15
provide insight into the chromosomal and clinical features, which are more heterogeneous than
previously thought (Roberts et al., 2003: Wang et al., 2004).
The Prader-Willi/Angelman critical region (PWACR), located on the 15q11-q14 locus, is
prone to forming complex chromosomal rearrangements (CCR). Detailed analysis of variations
in supernumerary marker chromosomes (SMCs) can lend itself to establishing clinical diagnostic
criteria (Roberts et al., 2003; Wang et al., 2004). The 15q11.2-q13 region is associated with two
distinct and characteristic syndromes known as Prader-Willi syndrome (PWS) and Angelman
syndrome (AS), which result from either loss-of-function or overexpression of at least 1
imprinted gene in the PWACR. These conditions are both associated with delayed
developmental milestones, hypopigmentation, and various central nervous system pathologies
(Buiting, 2010) (Kalsner and Chamberlain, 2015). While clinical diagnostic criteria for these
syndromes are delineated, those for 15q triplication syndrome are yet to be established. These
classic symptoms allow clinicians to more effectively establish diagnosis of individuals with
PWS/AS based on phenotypic patterns and order confirmatory array comparative genomic
hybridization (CGH) studies accordingly: a strategy of early intervention that is crucial to
maximizing the child’s communicative ability (Ben-Itzchak and Zachor, 2007).
The interstitial triplications of 15q11–q13 are rare and so far only 12 patients are reported
in the literature (Pettigrew et al., 1987; Clayton-Smith et al., 1993; Holowinsky et al., 1993;
Schinzel et al., 1994; Crawford et al., 1995; Cassidy et al., 1996; Chadwick et al., 1996; Long et
al., 1998; Reddy and Logan, 2000; Ungaro et al., 2001; Vialard et al., 2003; Castronovo et al.,

2014). The 15q11-13 interstitial triplication of the PWACR leads to tetrasomy of this region and
the affected individuals correlate with a range of features including mild facial dysmorphism,
moderate to severe behavioral and neurodevelopmental impairment, movement disorders,
hypotonia, and seizures (Castronovo et al., 2014). While there are different cytogenetic tests used
for clinical purposes to identify chromosomal rearrangements, microarray analysis elucidates the
structure of these chromosomal rearrangements with the accurate location of the breakpoints
(Wang et al., 2004).
Our patient, a child with a 15q11-13 interstitial triplication, represents yet another clinical
manifestation of cytogenetic abnormality in this region. The lack of an established genotypephenotype correlation often contributes to the medical fragility of CMC and hinders physicians
from providing patients with an established diagnosis and resulting plan of care for known
sequelae of the disease process (Cohen et al., 2011). This is especially true in regions where
access to clinical genetic evaluation is limited, and clinical suspicion of a genetic condition must
be high in order to accurately refer patients to a clinical geneticist (Fraiman and Wojcik, 2020).
To provide CMC with timely coordinated care, further studies are necessary to identify the
relationship between copy number variations and clinical phenotype, allowing for better clinical
suspicion leading to mitigation of unequal access to genetic testing (Fraiman and Wojcik, 2020).

Clinical Report:
The patient is a Hispanic female and the first-born child of healthy, nonconsanguineous parents. She has a younger brother who is four years of age with autism
spectrum disorder (ASD). Pregnancy was complicated by unspecified arrhythmias during the
last few months of pregnancy for which she took metoprolol. Gestational age was 40 weeks.
Birth weight was 3,062 g (~ 35th centile) and length was approximately 48 cm (~32nd
centile).
During the neonatal period, the patient presented with feeding difficulties starting
with suctioning. Soon after, the parents noted concern for her “floppy” appearance as she
could not hold her head up. According to the neurodevelopmental assessment, the patient
displays significant developmental delays with an overall low level of function. The patient

was not able to sit up unaided until after one year of age and began to walk unaided at the age
of three years. Her range of speech is using one to three-word sentences.
Further, the patient developed behavioral issues such as self-injury to the head,
dermatophagia of the fingers, trichotillomania, and trichophagia; however, these issues have
largely reduced due to therapies. She exhibits repetitive language and motor stereotypes and
tends to isolate herself rather than play with others. The child tends to stay busy, pace around
the house, and displays significant auditory defensiveness. The parents have also noticed
sleep disturbances in the child as she wakes once in the middle of the night for a few hours
daily. The patient is active throughout the day, participates in school for half days, and
receives developmental services through her school.
Finally, the patient was also noted to have two episodes of seizure-like activity at the
ages of one and four-years-old. The child was found by her parents during the night in an
unresponsive state with an arched back and was taken to the hospital after the second
episode. Electroencephalogram results revealed a normal awake pattern with no
abnormalities. No further episodes of seizure-like activity have occurred. MRI was not
obtained at time of initial episodes.
On the basis of suspecting a genetic syndrome, the primary care physician ordered
cytogenetic studies when the child was 18 months old. The patient was brought to us with a
confirmed diagnosis of autism spectrum disorder upon assessment by her primary care
physician at the age of 2 years.

Figure 1: Front facial views of patient at the ages of 4-years old (A), 5-years-old (B), and 6years-old (C), showing arched eyebrows, bilateral epicanthus, midface hypoplasia, long
philtrum, and thin upper lip.

Upon physical exam at the age of five years old with our developmental pediatrician,
the child was 17.47 kg (~19th centile), 44.75 in (~55th centile), and had a BMI of 13.5 (~6th
centile). When seen by our medical geneticist at the age of six years old, the patient was
observed to have various dysmorphic features (Figure 1) including left strabismus, arched
eyebrows, bilateral epicanthus, depressed nasal bridge with a short nose, long philtrum, thin
upper lip, high and narrow palate, a hypoplastic midface, and a cafe-au-lait macule on the left
pectoral region. Further, the clinical exam showed proximal hypotonia, hyperlordosis,
scoliosis, and zygodactyly in 2-3 toes bilaterally. The patient’s gait was wide and ataxic with
intoeing and truncal hypotonia.
Over the course of four years of speech, occupational, and physical therapy, the child
has gained significant function. Physical therapy has improved the patient’s hypotonia and
gait. Verbal improvement is notable for development of 100% intelligible speech and
communication in 4-word sentences, with a drastic increase in vocabulary size to more than
100 words.

Methods:
For SNP Microarray analysis, genomic DNA was extracted from whole blood using
RevealⓇ SNP Microarray Pediatric Kit. The assay evaluates whole-genome SNP-based copy
number microarray analysis targeting 2.695 million-copy-number and allele-specific genome
sites. Limitations of this assay include the inability to detect balanced rearrangements or lowlevel mosaicism.
Methylation analysis of SNRPN was performed by Southern blot using methyl
sensitive restriction enzymes. The methylation status was determined by methylation-specific
PCR and capillary electrophoresis; however, mosaicism and abnormal causes of PWS/AS
cannot be detected by this method.
Consent for patient photographs to be reviewed and possibly published was given by
the patient’s parents. Written informed consent for patient participation in this study was
provided by one of the parents, and the study was approved by the Institutional Review
Board at The University of Texas at Rio Grande Valley.

Results:

An SNP-based chromosome microarray was performed on DNA from the proband,
revealing a triplication and duplication mapped to the 15q11-q13 region. The multiplications
are not yet reported in the Database of Genomic Variants (DGV,
http://dgv.tcag.ca/dgv/app/home). No mosaicism was detected in the analysis, but may still
be present in other tissues below the level detectable by the array. The triplication was
mapped to the 15q11.2q13.1 region, including the Prader Willi/ Angelman syndrome critical
region, providing four doses of approximately 6.05 MB (chr15: 22,770,421 - 28,823,722,
hg19). The triplication is continuous, presumed to be de novo, and the cause of the pathologic
phenotype of the patient.
Furthermore, the duplication reported in the patient is composed of the more distal
interstitial segment BP3 to BP5 corresponding to 15q13.1q13.3, and is approximately 3.48
MB (chr15: 28,958,779 - 32,439,233, hg19). Due to genomic imprinting in this region,
phenotypic features of the triplication/duplication vary based on the parental chromosome of
origin. Because we were unable to pursue genetic testing of the parents, the etiology of the
triplication/duplication is unknown but presumed to be de novo due to the tendency of this
region of chromosome 15 to be prone to errors.
Microarray results performed for both parents revealed no rearrangements in the
PWACR. The father’s microarray results revealed a 16q23.1 deletion partially overlapping a
single disease-associated gene (ADAMTS18) as well as a region of homozygosity in
chromosome 9q22.32-q31.2, reported as variants of uncertain significance likely unrelated to
the patient’s condition. Methylation studies performed on the patient’s mother revealed a
lack of any rearrangements in this region. The patient’s brother with ASD had negative
results from microarray testing.

Discussion:
We report a new case of interstitial triplication of chromosomal region 15q11-q13
in a patient who is the first to display all phenotypic features previously recognized to be
associated with this condition, as shown in Table 1 (Pettigrew et al., 1987; Clayton-Smith et
al., 1993; Holowinsky et al., 1993; Schinzel et al., 1994; Crawford et al., 1995; Cassidy et al.,
1996; Chadwick et al., 1996; Long et al., 1998; Reddy and Logan, 2000; Ungaro et al., 2001;
Vialard et al., 2003; Castronovo et al., 2014). Although our patient carried a more distal

interstitial duplication, we attribute the phenotypic features to the large proximal triplication
due to its inclusion of the PWACR, which is associated with similar patterns of pathology.
However, due to the correlation between increased rates of microdeletions/ microduplications
among patients with intellectual delay, the impact of this smaller mutation cannot be ignored
(Liehr and Weise, 2007; Jafari‑Ghahfarokhi et al., 2014; Burnside et al. 2011).

Table I: Comparison of spectrum of phenotypic features present in previous patients as
compared to two patients with an additional CCR.

Symptom/Condition

Present
(+/-)

Castronovo
Patient

Fraction of reported patients with
symptom (n=12)

+
Hypotonia

+

5/12 (41.7%)
+

Seizures

+

5/12 (41.7%)
+

Ataxia

+

4/12 (33%)
+

Developmental Delay

+

11/12 (91.7%)
+

Intellectual Delay

+

9/12 (75%)
+

Autism Spectrum
Disorder

+

2/12 (16.7%)
-

Behavioral problems

+

6/12 (50%)
+

Craniofacial
dysmorphism

+

9/12 (75%)

A clear understanding of common breakpoint locations can improve our
understanding how varying gene dosage impacts resultant phenotypic features. Most
deletions and duplications of the PWACR share breakpoint locations resulting in a largely
consistent rearrangement length of ~4 Mb. These rearrangements usually share proximal
breakpoints, BP1 and BP2, and distal breakpoints, BP3, BP4, and BP5. However, due to the
use of different probes and PCR loci in previous studies, we can only speculate on the exact
location of the more distal breakpoints, BP4 and BP5 (Roberts et al., 2003)

Figure 2: Schematic view comparing location of triplications and complex chromosomal
rearrangements of previously reported cases.

Of the 12 previously reported cases, we could estimate the locations of six
rearrangements with the provided cytogenetic information (Figure 1). Four patients had a
common proximal breakpoint location between BP1 and BP2, present in our patient as well
(Pettigrew et al., 1987; Holowinsky et al., 1993; Schinzel et al., 1994; Ungaro et al., 2001).
Two patients shared a proximal breakpoint distal to BP2 (Clayton-Smith et al., 1993;
Castronovo et al., 2014). These rearrangements resulted in a shared tetrasomy of the
CYPFIP1, NIPA2, NIPA1, MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A,
GABRB3, GABRA5, GABRG3, OCA2, HERC2, and APBA2 genes. Of these six cases, four
patients had a more distal breakpoint resulting in additional tetrasomy of the TJP1 gene
(Holowinsky et al., 1993; Schinzel et al., 1994, Clayton-Smith et al., 1993; Castronovo et al.,
2014). To date, few of these genes have evidence for dosage pathogenicity (National Center
for Biotechnology Information. ClinVar; [VCV000397435.1],
https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000397435.1). While there is sufficient
evidence for dosage pathogenicity of UBE3A little evidence of pathogenicity for MAGEL2
and SNURF, this evidence is largely related to deletion or methylation of the genes.
However, due to the few number of cases reporting tetrasomy of the PWACR, data is not yet
available to propose pathogenicity of over-dosage of genes in this region.
It has been hypothesized that the origin of the chromosome with the triplication
impacts whether phenotypic features of the resulting tetrasomy resemble PWS or AS
(Castronovo et al., 2014). Like previous studies, our present patient also shares several
features seen in PWS/AS such as hypotonia, movement disorders, seizures, global DD, and
various behavioral impairments; however, our patient presents a more severe
neuropsychological phenotype seen commonly in Angelman syndrome, which results from
deletion of maternal imprinted genes. These findings support 2 hypotheses relating overdosage of imprinted genes in the PWACR to phenotypic presentation similar to PWS/AS:
either that excess dosage of these genes behave similarly to PWS/AS, in which there is null
dosage of the same genes, or that it presents similarly to the null dosage of the same genes
due to a position effect mediated by the CCR (Castronovo et al., 2014).
Our present patient is notable for the spectrum of her phenotypic features, as well as
the length of her CCR. She is the second of twelve patients with an additional duplication
involving the PWACR. While Castronovo’s patient has a ~1.1 Mb duplication in the

proximal region of the PWACR between BP1 and BP2, our patient displays a larger, more
distal ~3.48 Mb duplication spanning between BP3 and BP5. Both patients display more
severe features such as seizures, autism spectrum disorder, and global DD, which we
hypothesize may be the result of a position effect mediated by the additional dosage of
flanking genes. In Castronovo’s patient, there is duplication of the TUBGCP5, CYPFIP1,
NIPA2, and NIPA1 genes resulting in one extra dose. In contrast, our patient’s over-dosage
from duplication involves more distal genes including APBA2, TJP1, CHRFAM7A, TRPM1,
and CHRNA7.
Our patient’s CCR is spans the largest region reported so far of ~9.53 Mb, more than
twice the length of the typical ~4 Mb length of deletions recorded in PWS/AS (Roberts). We
hypothesize the severity of her phenotype involving the full range of previously documented
features could be a result of potentiating effects of the large distal duplication on the more
proximal interstitial triplication.
The patients with this condition have reported neurodevelopmental impairment in all
the cases so far, and our patient supports this understanding that 15q11-13 triplication
syndrome presents with severe DD especially affecting speech and cognitive function
(Pettigrew et al., 1987; Clayton-Smith et al., 1993; Holowinsky et al., 1993; Schinzel et al.,
1994; Crawford et al., 1995; Cassidy et al., 1996; Chadwick et al., 1996; Long et al., 1998;
Reddy and Logan, 2000; Ungaro et al., 2001; Vialard et al., 2003; Castronovo et al., 2014).
Despite the severe neurological presentation associated with our patient, speech therapy has
tremendously aided her progress: increasing her vocabulary from 20 to more than 100 words
with the ability to communicate in sentences. In addition, our patient has continued to
develop a propensity for puzzles, dancing, and social interaction. The focus on sufficient
speech and behavioral therapies for our patient is a critical representation of the long-term
benefits of early intervention.
In conclusion, the data provided by our study contributes to the developing genotypephenotype correlation and analysis of breakpoints in the PWACR. As the complexity of
breakpoint heterogeneity is revealed, the need for expanded genomic data diversity becomes
increasingly necessary to better understand the pathogenesis of over-dosage of these
imprinted genes, especially for populations who are under-represented in genomic databases.
Our study also highlights the benefits of early diagnosis and intervention for complex care

children such as our patient, and advocates for ensure nondiscriminatory access to
specialized clinical care to support equal representation in genomic databases (Landry et al.,
Kutscher et al., 2017). With expanded access to specialized genetic care, it will be possible to
strengthen the diversity of genomic databases, paving the way for promising analysis of
complex chromosomal rearrangements to better understand pathogenesis, prognosis, and
treatment for complex-care children.
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